TMCI - Treace Medical Concepts, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 1.60B
Enterprise value 1.59B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.75
Price/book (mrq)25.32
Enterprise value/revenue 10.25
Enterprise value/EBITDA -39.95

Trading information

Stock price history

Beta (5Y monthly) -0.01
52-week change 357.28%
S&P500 52-week change 31.77%
52-week high 327.97
52-week low 313.19
50-day moving average 325.63
200-day moving average 323.42

Share statistics

Avg vol (3-month) 3389.15k
Avg vol (10-day) 3254.87k
Shares outstanding 561.33M
Implied shares outstanding 6N/A
Float 842.03M
% held by insiders 131.74%
% held by institutions 150.03%
Shares short (14 May 2023) 41.37M
Short ratio (14 May 2023) 44.65
Short % of float (14 May 2023) 44.05%
Short % of shares outstanding (14 May 2023) 42.24%
Shares short (prior month 13 Apr 2023) 41.74M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin -30.48%
Operating margin (ttm)-26.15%

Management effectiveness

Return on assets (ttm)-12.80%
Return on equity (ttm)-38.65%

Income statement

Revenue (ttm)154.99M
Revenue per share (ttm)2.76
Quarterly revenue growth (yoy)45.30%
Gross profit (ttm)114.31M
Net income avi to common (ttm)-47.23M
Diluted EPS (ttm)-0.85
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)170.66M
Total cash per share (mrq)2.78
Total debt (mrq)68.58M
Total debt/equity (mrq)43.51
Current ratio (mrq)9.58
Book value per share (mrq)2.57

Cash flow statement

Operating cash flow (ttm)-40.67M
Levered free cash flow (ttm)-46.37M